← Back
$AKBA All transactions

Akebia Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$49K

Shares

34,951

Price

$1

Filed

Feb 4

Insider

Name

Ostrowski Erik

Title

SVP, CFO, CBO & Treasurer

CIK

0001762507

Roles

Officer

Transaction Details

Transaction Date

2026-02-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

672,635

Footnotes

This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2025. | This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025.

Filing Info

Accession No.

0001762507-26-000002

Form Type

4

Issuer CIK

0001517022

Ostrowski Erik's History

Date Ticker Type Value
2026-02-02 AKBA $49K
2026-01-30 AKBA A $0
2026-01-30 AKBA A $0
2025-06-30 AKBA $152K

Other Insiders at AKBA (90d)

Insider Bought Sold Last
Butler John P.
CEO and President
$474K 2026-02-02
Burke Steven Keith
SVP, Chief Medical Officer
$94K 2026-02-02
Vickers Philip J. 2026-04-01
Grund Nicholas
Chief Commercial Officer
$118K 2026-02-02
Ostrowski Erik
SVP, CFO, CBO & Treasurer
2026-01-30
Malabre Richard C
SVP, Chief Accounting Officer
$69K 2026-02-02
Rucci Carolyn M.
SVP, Chief Legal Officer
$97K 2026-02-02